DM

Dhavalkumar Maganlal Patel

Active Director Designated Partner DIN 11621813
DIN 11621813 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Dhavalkumar Maganlal Patel

Data last updated:

Dhavalkumar Maganlal Patel is a Designated Partner at Seravia Life Sciences Llp (since 2026).

DIN 11621813
Primary Designation Designated Partner
First Appointment 20 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Mar 20262026Active

Board colleagues of Dhavalkumar Maganlal Patel

NameDINCompanyDesignation
Kokilaben Maganlal Patel11621814Seravia Life Sciences LlpDesignated Partner
Maganlal Ambalal Patel11621812Seravia Life Sciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Seravia Life Sciences Llp
Premium access

Shareholding and investment profile for Dhavalkumar Maganlal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhavalkumar Maganlal Patel

Dhavalkumar Maganlal Patel currently holds 1 directorship: Seravia Life Sciences Llp (Designated Partner, since 20 Mar 2026).

Dhavalkumar Maganlal Patel was first appointed on 20 Mar 2026 as Designated Partner at Seravia Life Sciences Llp.

The current boards of Dhavalkumar Maganlal Patel's companies include Kokilaben Maganlal Patel (Seravia Life Sciences Llp), Maganlal Ambalal Patel (Seravia Life Sciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available